New Hope in Cancer: A Panel Discussion - Dr Richard Sidebottom, Sanjay Popat and James Larkin

  Рет қаралды 2,333

Gresham College

Gresham College

2 ай бұрын

Enjoying our lectures? Please take a minute to answer 4 questions to tell us what you think!
app.sli.do/event/1JonWUnuRtwj...
In partnership with Novartis
Treatments and research in cancer are moving very fast, giving new hope to many.
This event will bring together speakers in the series to delve further into new treatments and research in cancer, including immunotherapy, genomics and AI imaging.
This lecture was recorded by Parker Moss, Dr Richard Sidebottom, Sanjay Popat and James Larken on 12th March 2024 at Barnard's Inn Hall, London
Parker is a member of the Secretary of State for Health's technology advisory board. He is currently Chief Commercial & Partnerships Officer at Genomics England.
Richard works clinically as part of the breast imaging team at Cheltenham and holds a research radiology post at The Royal Marsden Hospital as part of the AI imaging hub team.
Professor Sanjay Popat is a Consultant Thoracic Medical Oncologist at the Royal Marsden Hospital and Professor of Thoracic Oncology at the Institute of Cancer Research.
James is a Medical Oncologist specialising in the treatment of melanoma and cancers of the kidney.
The transcript and downloadable versions of the lecture are available from the Gresham College website:
www.gresham.ac.uk/watch-now/c...
Gresham College has offered free public lectures for over 400 years, thanks to the generosity of our supporters. There are currently over 2,500 lectures free to access. We believe that everyone should have the opportunity to learn from some of the greatest minds. To support Gresham's mission, please consider making a donation: gresham.ac.uk/support/
Website: gresham.ac.uk
Twitter: / greshamcollege
Facebook: / greshamcollege
Instagram: / greshamcollege

Пікірлер: 4
@bobd4563
@bobd4563 2 ай бұрын
With so many cancer cases recently diagnosed and the root causes still hidden from the public, I guess more illumination in many wavelengths is to be applauded
@ryanwdavies1
@ryanwdavies1 Ай бұрын
@Llooktook
@Llooktook Ай бұрын
My question is, how much of these front funning emerging therapies area actually available at a large scale for the population? From my own experience, a large proportion of people are still being treated with the same drugs and therapies that someone 20 years ago was offered.
Stanford Cancer Institute Breakthroughs in Cancer: Luis Diaz, MD
58:31
Stanford Cancer Institute
Рет қаралды 9 М.
Who’s more flexible:💖 or 💚? @milanaroller
00:14
Diana Belitskay
Рет қаралды 19 МЛН
КАРМАНЧИК 2 СЕЗОН 6 СЕРИЯ
21:57
Inter Production
Рет қаралды 517 М.
Чай будешь? #чайбудешь
00:14
ПАРОДИИ НА ИЗВЕСТНЫЕ ТРЕКИ
Рет қаралды 2,7 МЛН
ELE QUEBROU A TAÇA DE FUTEBOL
00:45
Matheus Kriwat
Рет қаралды 34 МЛН
Cancer Immunotherapy: 2022 Research and a Look Ahead with E. John Wherry, Ph.D.
54:34
Cancer Research Institute
Рет қаралды 73 М.
Dyslexia and Language - Disorder or Difference? - Maggie Snowling CBE
1:01:16
think ahead: Breakthrough growth and how to achieve it
54:14
London Business School
Рет қаралды 4 М.
Evolution Tomorrow and Beyond - Robin May
1:00:26
Gresham College
Рет қаралды 10 М.
What went wrong in Latin America? - Martin Daunton
1:10:28
Gresham College
Рет қаралды 34 М.
Lung Cancer Staging: IASLC 8th Edition
15:23
Society of Thoracic Radiology
Рет қаралды 1,7 М.
Why Israel is in deep trouble: John Mearsheimer with Tom Switzer
1:35:01
Centre for Independent Studies
Рет қаралды 2,9 МЛН
Is it Aliens? The Most Unusual Star in the Galaxy - Chris Lintott
1:05:41
The Next Fifty Years of Tech - Professor Victoria Baines
1:03:54
Gresham College
Рет қаралды 4,4 М.
Who’s more flexible:💖 or 💚? @milanaroller
00:14
Diana Belitskay
Рет қаралды 19 МЛН